The purpose of this study is to report our method in detecting prostate cancer (PCa) using an 18-core transrectal ultrasound (TRUS) prostate biopsy (PB) schema, in combination with additional targeted cores from suspicious images in conventional (e-cMRI) and functional (e-fMRI) endorectal magnetic resonance imaging (e-MRI) of the prostate. From 2004 to 2008, 260 consecutive patients with a clinical suspicion of PCa underwent PB and were prospectively studied. e-cMRI and e-fMRI was performed in all patients before PB. The patients were divided into two groups (A and B) according to the results of their radiological findings (group A ¼ suspicious findings, group B ¼ non-suspicious findings). After the images were processed, an 18-core TRUS-guided PB was performed. When a patient exhibited a suspicious site on e-cMRI and e-fMRI images, three additional targeted PBs were obtained from that site. In group A, 17.5% of PCa was detected by the 18-core PB and 56.5% of PCa was detected by the targeted cores. The overall PCa detection rate (18 þ targeted cores) was 73.9%. The overall specificity was 73.9%. In group B, overall false-positive detection rate reached 19.2%, with the overall sensitivity being 80.8%. The method described above is not only practical but also a promising modality in PCa detection. As seen, PCa was optimally detected when combining the 18-core and targeted-core PB schema together. Non-suspicious images do not rule out the probability of PCa, thus justifying a PB in these patients as well.
Introduction
Prostate cancer (PCa) has become a leading cause of morbidity and mortality in men in the Western countries. The main diagnostic problems for clinicians concerned with PCa include early detection, localization and staging, as well as prediction of individual aggressiveness. For curative treatment the identification of early tumor stage in asymptomatic individuals is crucial. Although early detection has been significantly improved using PSA testing and the rapid increase of PCa incidence during the past two decades can partially be explained by this serum test, 1 diagnosis is achieved by means of a systematic prostate biopsy (PB). On the basis of a Medline database search in 2007, Fink et al. 2 found more than 1024 published papers dealing with the subject of PB. They cover topics, such as indication, antibiotic prophylaxis, use of enema and, more recently, the details of the technique like number of cores, their location or when, how and how often a PB should be repeated. The fact that no procedural algorithm is uniformly followed, in terms of indication, method and number of cores, among urologists in major European countries, as well as in the United States is noteworthy. 3 Since the early 1980s, magnetic resonance imaging (MRI) has been available for use as a staging modality in PCa. 4 Currently used indications of prostate MRI include PCa detection and staging in patients with diagnosed cancer for treatment planning, and guided PB based on abnormalities detected by MRI. 5 The purpose of this study is to report our method in detecting PCa using an 18-core transrectal ultrasound (TRUS) PB schema, in combination with additional targeted cores from suspicious images in conventional (ecMRI) and functional (e-fMRI) endorectal MRI (e-MRI) of the prostate.
Patients and methods
The study, use of devices and procedures described here were approved by the institutional human ethics board, and all participants were informed in detail before obtaining their written consent to participate in the study.
From 2004 to 2008, 260 consecutive patients with a clinical suspicion of PCa underwent a TRUS-guided PB and were prospectively studied. e-cMRI and e-fMRI was performed in all patients before PB. The patients were divided into two groups (A and B) according to the results of their radiological findings (group A ¼ suspicious findings, group B ¼ non-suspicious findings). After the images were processed, an 18-core TRUSguided PB was performed. When a patient exhibited a suspicious site on e-cMRI and e-fMRI images, three additional targeted PBs were obtained from that site.
Inclusion criteria for the study were one of the following: increased PSA levels (44 ng ml
À1
), a suspicious finding on digital rectal examination and at least one previous negative PB. Exclusion criteria were patient age 475 years, cardiac pacemaker, history of pelvic surgery, inflammatory bowel disease (Crohn's disease or ulcerative colitis), external beam radiation to the pelvis, anal stricture or severe hemorrhoids interfering with endorectal receiver positioning.
The examinations were carried out on a closed 1.0-T system (MAGNETOM Harmony, Siemens Medical Solutions, Erlangen, Germany) combined with an endorectal body phased-array coil (Comp. MEDRAD, Pittsburg, PA, USA). After insertion of the endorectal coil, e-cMRI T1-and T2-weighted sequences were derived from the prostate apex up to the seminal vesicles. T2-weighted sequences were applied in axial (repetition time (TR) 4500 ms, echo time (TE) 105 ms, slice thickness (SD) 3 mm, slice distance (GAP) 0.25, field of view (FOV) 160 mm, matrix 256 Â 90) and in coronal slice orientation (TR 5230 ms, TE 124 ms, SD 3 mm, GAP 0.10, FOV 200 mm, matrix 256 Â 90). T1-weighted axial turbo-spinecho sequences were applied in axial slice orientation (TR 557 ms, TE 15 ms, SD 4 mm, GAP 0.25, FOV 160 mm, matrix 256 Â 88). In addition, T1-weighted axial-oriented turbo-spin-echo sequences (TR 734 ms, TE 12 ms, SD 5 mm, GAP 0.2, FOV 300 mm, matrix 256 Â 100) were applied through the regional lymph drain path from the prostate base up to the aorta bifurcation.
In addition, efMRI was performed and included endorectal dynamic contrast material-enhanced MRI and diffusion-weighted imaging (DWI). After injection an intravenous bolus injection of gadodiamide (Omniscan, Oslo, Nycomed-Amersham, Norway; dose 0.1 mmol kg À1 injected within 10 s followed by a 20-ml flush of normal saline) with a power injector and with a time resolution of 25 s, T1-weighted axial turbo-spinecho sequences were again applied in axial slice orientation (TR 5.35 ms, TE 2.57 ms, SD 3 mm, GAP 0.2, FOV 300 mm, matrix 132 Â 70) from the prostate apex up to the seminal vesicles. In DWI, T2-weighted sequences were applied in axial slice orientation. DWI parameters were TR 4000 ms, TE 113 ms, SD 5 mm, GAP 0.3, FOV 300 mm and matrix 128 Â 100. The total time the patients spent in the magnet during the MRI examinations was B30 min.
All studies were read and interpreted by a dedicated radiologist blinded to patients' clinical data. e-MRI morphological images were analyzed and regarded as suspicious or non-suspicious for PCa.
In addition, probable extracapsular extension (ECE) of the tumor, seminal vesicle invasion (SVI) and neurovascular bundle (NVB) involvement was noted.
e-MRI techniques and interpretation e-cMRI. Conventional e-MRI reveals morphological information using T1-and T2-weighted images with an endorectal coil. The prostate shows uniform intermediate signal intensity at T1-weighted imaging, although the zonal anatomy cannot be clearly identified. Consequently, T1-weighted axial images of the pelvic region are used for the detection of NVB involvement, ECE and lymph node metastases. 6 Areas with displacement or vanishing of the NVBs were presumed as NVB involvement. Asymmetry of the periprostatic fat, irregular bulging of the prostatic contour and vanishing of the NVBs was presumed as ECE. The presence of one or more nodes with a short axis diameter 41 cm was considered as lymph node metastasis.
For tumor detection, localization and local-extent T2-weighted images are used. On T2-weighted images PCa most commonly shows decreased (low) signal intensity within the normal peripheral zone 7 ( Figure 1a and b). Consequently T2-weighted axial images of the pelvic region were used for the detection of PCa, ECE, SVI and NVB involvement. Areas within the prostate gland showing a low signal intensity and obliteration of the rectoprostatic angle were interpreted as areas with cancer. Irregular bulging of the prostatic contour, contiguous tumor signal intensity within the periprostatic fat and vanishing of the NVB were presumed as ECE. Diagnostic criteria for NVB involvement included their vanishing or/and asymmetry. Focal low signal intensity lesions within the seminal vesicle or direct extension of low-intensity mass from prostate to the seminal vesicle were presumed as SVI.
e-fMRI. Currently used e-fMRI techniques include endorectal dynamic contrast material-enhanced MRI, DWI and spectroscopy. dce-MRI has been shown to significantly improve tissue characterization, and both the dynamic parameters of the contrast enhancement and the pharmacokinetic modeling parameters have been used in diagnosing and staging PCa. It is well known that the number of vessels increases in cancerous tissue, and tumor vessels have a greater permeability. 8 Experimental studies have shown that contrast enhancement parameters, such as mean transit time, blood flow, permeability surface area and interstitial volume, are significantly higher in cancerous tissue than in normal tissue, and therefore allow differentiation between benign and malignant tissue.
9 T1-weighted sequences were used only for the detection of PCa and SVI. Areas within the prostate gland exhibiting an early PCa detection using an extended prostate biopsy schema AP Labanaris et al enhancement were interpreted as areas with cancer ( Figure 2a ). Early enhancement within the seminal vesicle or extension of the enhancement from the prostate to the seminal vesicles was presumed as SVI. The DWI properties of tissue are in close association with the amount of interstitial free water and permeability. Cancer tends to have more restricted diffusion than normal tissue because of the higher cell densities and excess of intra-and intercellular membranes in cancer 10 ( Figure 2b ). T2-weighted sequences were used only for the detection of PCa and not for the detection of ECE, SVI and NVB involvement.
All images obtained from the e-ctMRI and e-ftMRI were then compared with each other and then were regarded as suspicious or non-suspicious for PCa. Details of ECE, SVI and NVB involvement are not mentioned as they are beyond the scope of this article. Only a visual evaluation was carried out by the reader to predict an abnormal region in the organ. PCa detection using an extended prostate biopsy schema AP Labanaris et al PB Transrectal ultrasound PBs were performed with a Siemens Allegra ultrasound machine with a 6.5 MHz sector probe in both studies. After optimizing the image of the peripheral zone, the prostate was imaged from the base to apex in the axial and then in the sagittal planes, and biopsies were performed using a standard springloaded biopsy device in the sagittal plane in accordance with the study protocol. Cores were obtained using an 18-gauge biopsy needle (Bard Urological, Covington, GA, USA) with a spring-loaded Biopty Gun (Manan). After the images were processed, an 18-core TRUSguided PB was performed. When a patient exhibited a suspicious site on e-cMRI and e-fMRI images, three additional targeted PBs were obtained from that site (Figure 3) . If a patient exhibited multifocal suspicious areas, then all suspicious areas underwent an additional three targeted biopsies individually. Biopsies were reviewed by a member of the Department of Pathology. The grade and amount of cancer in each core were recorded along with the number of cores and the location of each core. All cores obtained from the additional targeted biopsies were separately reviewed in order not to affect the interpretation of cancer from one set to the other.
Results
The clinicopathological parameters of both groups including PCa detection rate individually for both groups are summarized in Table 1. Group A included N ¼ 170 patients with a median age of 67.2 years at presentation. PSA levels were between 1.3 and 45.3 ng ml À1 with a median of 8.3 ng ml À1 . Overall PCa detection rate was 73.9%. Overall detection of PCa according to PSA levels was 71.1% for levels o4 ng ml À1 , 72.5% for levels between 4 and 10 ng ml À1 , 76.2% for levels between 10 and 20 ng ml À1 and 81.5% for levels 420 ng ml
À1
. Overall, sensitivity was 73.9%. For 87.2% of patients, this was their second PB, for 8.1% their third and for 4.7% their forth biopsy. Overall PCa detection rate in the targeted cores was 56.4%. PCa detection rate in the targeted cores according to PSA levels was 67.9% for levels o4 ng ml À1 , 52.3% for levels between 4 and 10 ng ml À1 , 57.6% for levels between 10 and 20 ng ml À1 and 76.8% for levels 420 ng ml À1 . Overall PCa detection rate in the I8-core PB was 17.5%. PCa detection rate in the I8-core PB according to PSA levels was 1.4% for levels o4 ng ml À1 , 20.2% for levels between 4 and 10 ng ml À1 , 18.6% for levels between 10 and 20 ng ml À1 and 4.7% for levels 420 ng ml
. Figure 3 Demonstration of the 18-core transrectal ultrasound-guided prostate biopsy (PB) in the sagital (left panel) and in the axial plane (right panel). When a patient exhibited a suspicious site on conventional endorectal magnetic resonance imaging (e-MRI) and functional e-MRI images, three additional targeted PBs (arrow) were obtained from that site (circle). The ' Â ' symbol and ' þ ' symbol indicate the prostate length in the sagital plane and the length of the lobe in axial plane respectively (Figures 1-4) . . Overall, specificity was 80.8%.
Concerning morbidity, macroscopic hematuria occurred in 73% of patients and lasted an average of 4 days (range 1-18); hematospermia occurred in 56% of patients and lasted an average of 11 days (range 1-30). Minor rectal bleeding, lasting an average of 1.3 days (range: 0-15), was reported by 37% of patients. Prostatic infection (fever and required hospitalization) occurred in 2 of 173 patients.
Discussion
About one-third of men 450 years of age will harbor PCa at autopsy, whereas men's lifetime probability of developing invasive cancer is estimated to be 16.7%. 11 In studies on incidental PCa at autopsy, cancer was present in 2, 29, 32, 55 and 64% of men in their third, fourth, fifth, sixth and seventh decades, respectively. 12 Despite years of research, the exact number of PB to be taken to detect PCa and to predict the actual tumor volume is still unknown. 13 Throughout the years various PB protocols (according to number of cores) have been used, but only the sextant PB introduced by Hodge et al.
14 in 1989 was considered a standard method of TRUS-guided PB. However, in the recent years, its efficiency has been questioned and most urologists have abandoned this method. Indeed, the sensitivity of sextant PB may be suboptimal for large-volume prostates, and it has been shown that the technique has a false-negative rate as great as 30%. 15 Between 13 and 41% of patients with a negative primary PB are diagnosed with PCa by repeated PB. 16 Furthermore, Crawford et al. 17 noted in a computer model that the sextant PB template misses 48-42% of significant PCa, of which the majority had a focus in the peripheral zone.
In the last decade, various protocols of PB have been described. Inahara et al. 18 performed an 8-core PB in 110 patients. The PCa detection rate was 14.5%. Philip et al. 19 carried out a study that included 445 patients who had a 12-core TRUS-guided PB. PCa was detected in 31.9% of patients. Inahara et al. 18 performed a 14-core PB in 94 patients. The cancer detection rate was 24.5%. In 2000, Borboroglu et al. 20 introduced the saturated PB, a schema that consisted of at least 20 cores. He performed an average of 22.5 cores in 57 men. PCa detection was 30%. Guichard et al. 21 performed a 21-core PB as the initial PB strategy in 1000 consecutive patients, with overall diagnostic yield of 42.5%. Stewart et al. 15 performed a 23-core PB in 224 men. PCa detection was 34%. Walz et al. 22 performed a 24-core PB in 161 men. PCa detection was 41%. These authors concluded that saturation PB represents a necessary and a safe diagnostic procedure for men with suspicion of PCa, with the accuracy of Gleason sum obtained from PB correlating with the final Gleason sum obtained from the radical prostatectomy specimen. 22 It is evident that even though several different extended PB techniques exist, the optimal protocol needed to identify all patients with PCa at the earliest stage possible for optimal treatment, outcome and survival is still unknown. Reliably diagnosing early PCa is a first step in improving the outcome of the management of this disease. e-MRI is accepted as the best imaging modality for detection and staging PCa because of its excellent depiction of the zonal anatomy and the relationship of the prostate gland to the surrounding structures in the pelvis. The routine use of dc-eMRI, DWI and MR spectroscopy increase significantly the sensitivity and the specificity of the T2-weighted sequences in the depiction and characterization of the PCa in the peripheral and the transition zones. The sensitivity for the detection of a PCa by e-MRT varies between 50 and 93%, depending on the study, and compared with TRUS, e-MRI offers a clearly higher sensitivity for the detection of a prostate tumor. 23 Vilanova et al. 24 showed a specificity of 76% and a sensitivity of 70% for prediction of positive PB using unenhanced MRI in a group of 81 patients. He performed a 6-core PB based on the findings and reported a 28% of PCa. Comet-Battle et al. 25 had similar results, with a sensitivity of 80% and specificity of 76% using sextant PB for correlation. Beyersdorff et al. 26 exhibited that T2-weighed e-MRI has increased diagnostic performance with a sensitivity of 83%. Yuen et al. 27 exhibited a sensitivity and specificity of 82.1 and 100%, with a PCa detection rate of 29.2%. Hara et al. 28 using dce-MRI achieved a sensitivity of 93% and a specificity of 96% in a group of 90 patients. PCa detection was 36.8%. The above-mentioned results were obtained with modern imaging techniques but still using conventional TRUS guidance. Anastasiadis et al. 29 achieved a cancer detection rate of 55.5% by guided e-MRI-guided biopsies, but only patients with suspicious MRI were selected; thus, a detection rate of 55.5% is not surprising. As seen from the results of group A, overall PCa detection rate was 73.9%, with 56.4% of this value being obtained through the targeted cores from the suspicious images and the rest 17.5% through the 18-core biopsy. Thus, the reason for the additional targeted cores obtained is obvious. The question is why were not only targeted biopsies performed in patients with suspicious images and why did patients with normal images undergo an 18-core biopsy? The answer is that our 18-core biopsy in group A provided us with 17.5% additional cases of PCa and in group B with 19.2% of additional cases. Therefore, it is evident that only by combining both schemas, maximal detection accuracy can be achieved and that nonsuspicious images do not rule out the probability of PCa, thus justifying a PB in these patients as well.
One other important question is how could one be certain that the TRUS PB sites truly corresponded to the e-MRI abnormal sites? The answer lies on the number of additional cores performed. With only a single additional core, one could expect that it would be on its best concentrated around the area of the e-MRI abnormality and not exactly on the e-MRI abnormality. By performing three additional targeted cores, one could expect that this possibility is diminished.
PCa detection using an extended prostate biopsy schema AP Labanaris et al As seen, a wide range of accuracy, sensitivity, specificity and predictive values was reported using various groups of patients and protocols. The reasons for this are likely multifactorial: patient selection, different protocols, differences in criteria used for interpretation and subspecialty experience of the radiologist. 6 Yu et al. 30 in a study of 77 patients who had stage pT2 (the tumor is confined within the prostate gland) or pT3 (the tumor has extended through the prostatic capsule and/or to the seminal vesicles, but no other organs are affected) PCa and whose MR images were retrospectively reviewed by three readers with varying experience in interpretation of endorectal coil images of the prostate gland showed that reader's experience have an important role. The reader with the most experience achieved the best results for sensitivity, specificity and accuracy, and the interpretations showed a statistically significantly greater area under the receiver operating characteristic curve than those of the less experienced readers.
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